


Kannoli Pharma Revenue
Pharmaceutical Manufacturing • Sintra, Lisbon, Portugal • 1-10 Employees
Kannoli Pharma revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Kannoli Pharma
Antonio Cabral
Owners Representative, Project Lead, Investor Relations
Company overview
| Headquarters | Rua do Campo, Sintra, 2710-476, PT |
| Phone number | +351911944171 |
| Website | |
| NAICS | 3254 |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
About Kannoli Pharma
Kannoli Pharma (“Kannoli”), a brand owned by Alkannoli L.D.A., is a new ’disruptor‘ in the nascent but fast growing European Medical Cannabis industry, with an overaching strategy to grow, extract and manufacture EU-GMP certified medical cannabis products, initially for the EU market. Kannoli’s expandable production facility will be a stand out environmental project, addressing the need for the production of consistent, high quality, and innovative cannabis products for the EU healthcare market. Medical Cannabis extracts and applications are used in the treatment of a wide range of diseases and symptoms, including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, etc.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Kannoli Pharma has never raised funding before.
Kannoli Pharma Tech Stack
Discover the technologies and tools that power Kannoli Pharma's digital infrastructure, from frameworks to analytics platforms.
Web servers
WordPress themes
Miscellaneous
Hosting
Programming languages
Hosting
Blogs
Databases
Miscellaneous
Font scripts
Frequently asked questions
4.8
40,000 users



